Status:
UNKNOWN
PTEN-AKT-FOXO3 Gene Expression Relation With Low-ovarian Reserve in Endometriomas
Lead Sponsor:
Uludag University
Conditions:
Ovarian Reserve, Endometrioma, PTEN-AKT-FOXO3 Gene Expression
Eligibility:
FEMALE
18-40 years
Brief Summary
In this study, we aimed to investigate the relationship between PTEN-AKT-FOXO3 gene expression and decrease in ovarian reserve in the presence of endometrioma and other benign ovarian pathologies.
Detailed Description
It is known that the presence of endometrioma negatively affects ovarian reserve. The development of endometriosis and the effect of the presence of endometrioma on ovarian reserve due to decreased PT...
Eligibility Criteria
Inclusion
- 1\) To be in the range of 18-40 years 2) Patients with an operation indication with \>=5 cm endometrioma 3) Patients with operation plan due to non-endometrioma ovarian pathologies
Exclusion
- 1)Patients over the age of 40 2)Patients with suspected malignancy 3)Follow-up patients without indications for operation
Key Trial Info
Start Date :
May 27 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04058912
Start Date
May 27 2019
End Date
June 30 2020
Last Update
August 16 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Uludag University Hospital, Department of Obstetrics and Gynecology
Bursa, Nilufer, Turkey (Türkiye), 16059
2
Uludag University Hospital, Department of Obstetrics and Gynecology
Bursa, Nilufer, Turkey (Türkiye), 16059